LakeShore Biopharma Co., Ltd - Warrants (LSBPW) Stock Price, News & Analysis

Company Overview

LakeShore Biopharma Co., Ltd. is a Cayman Islands–incorporated, clinical-stage biopharmaceutical company headquartered in Suzhou, China. The company is dedicated to the discovery, development and commercialization of innovative therapies, with a primary focus on immuno-oncology and fibrotic diseases. Leveraging an in-licensing strategy, LakeShore acquires early-stage drug candidates from academic institutions and biotechnology partners, then advances them through preclinical research and clinical trials using its integrated R&D platforms.

The company’s pipeline comprises both small molecule and biologic candidates that target mechanisms such as tumor microenvironment modulation, ferroptosis induction and anti-fibrotic pathways. Through its fully equipped facilities in Suzhou, LakeShore conducts host biology profiling, bioanalysis and process development in support of its lead programs. These efforts are complemented by collaborations with global research institutions, which provide access to specialized expertise and enable efficient progression of assets toward clinical proof-of-concept.

LakeShore Biopharma serves domestic and international markets via strategic partnerships designed to facilitate global development and future commercialization. The company completed its initial public offering on the Nasdaq Global Market in mid-2023, issuing ordinary shares and corresponding warrants that trade under the symbol LSBPW. Backed by a leadership team with deep experience in drug discovery, clinical development and regulatory affairs, LakeShore is positioned to advance its key assets toward potential regulatory submissions and commercial milestones.

Key Stats

• Today's Range: $0.03 to $0.03
• 50-Day Range: $0.02 to $0.04
• 52-Week Range: $0.01 to $0.11
• Volume: N/A
• Average Volume: 26,999 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

LSBPW Stock Analysis - Frequently Asked Questions

How have LSBPW shares performed this year?

LakeShore Biopharma Co., Ltd - Warrants' stock was trading at $0.0660 at the beginning of 2025. Since then, LSBPW shares have decreased by 59.8% and is now trading at $0.0265.

How do I buy shares of LakeShore Biopharma Co., Ltd - Warrants?

Shares of LSBPW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: NASDAQ:LSBPW
• CIK: 1946399
• Web: N/A
• Phone: N/A
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $614.96 million
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: N/A
• Beta: N/A